Filing Details

Accession Number:
0001127602-17-015802
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-04-28 07:37:25
Reporting Period:
2017-04-26
Filing Date:
2017-04-28
Accepted Time:
2017-04-28 07:37:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
859737 Hologic Inc HOLX X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844) 042902449
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1346770 M Lawrence Levy 250 Campus Drive
Marlborough MA 01752
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-04-26 8,874 $32.82 37,377 No 4 M Direct
Common Stock Disposition 2017-04-26 8,874 $44.47 28,503 No 4 S Direct
Common Stock Disposition 2017-04-26 1,500 $44.42 27,003 No 4 S Direct
Common Stock Acquisiton 2017-04-27 3,126 $32.82 30,129 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-qualified Stock Option (Right to Buy) Disposition 2017-04-26 8,874 $0.00 8,874 $32.82
Common Stock Non-qualified Stock Option (Right to Buy) Disposition 2017-04-27 3,126 $0.00 3,126 $32.82
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
67,126 2008-01-01 2017-10-22 No 4 M Direct
64,000 2008-01-01 2017-10-22 No 4 M Direct
Footnotes
  1. Transaction pursuant to an existing Rule 10b5-1 trading plan.
  2. The price reported is the weighted average exercise price per share. Shares were sold in multiple transactions at prices ranging from $44.201 to $44.65. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
  3. Includes 2,427 shares subject to deferral pursuant to the Issuer's Deferred Equity Plan.